Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of nucleoside analogs and boron-containing drugs. Its structure allows for Suzuki-Miyaura cross-coupling reactions, enabling the construction of complex molecules for medicinal chemistry. Commonly employed in research settings to design inhibitors targeting enzymes involved in metabolic and oncological pathways. Also explored in the preparation of bioactive molecules with antiviral and anticancer properties due to its ability to mimic pyrimidine bases while introducing boronic acid functionality for enhanced binding or targeting.